Fatty liver disease is a subset of the disparities that are characterized under the umbrella term metabolic syndrome. Fatty liver disease affects more than 20% of individuals […]
The Role of Naturally Occurring Stilbenoid TSG as a Therapeutic Agent for Non-alcoholic Fatty Liver Disease
